Eliminating hepatitis C within low-income countries – The need to cure genotypes 4, 5, 6
- 1 April 2018
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 68 (4) , 814-826
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- The NS5A Replication Complex Inhibitors: Difference Makers?Clinics in Liver Disease, 2011
- The unexpected discovery of a focus of hepatitis C virus genotype 5 in a Syrian provinceEpidemiology and Infection, 2008
- The epidemiology and virology of hepatitis C virus genotype 5 in central FranceAlimentary Pharmacology & Therapeutics, 2007
- Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective studyAlimentary Pharmacology & Therapeutics, 2006
- High Prevalence of Hepatitis C Virus Type 5 in Central France Evidenced by a Prospective Study from 1996 to 2002Journal of Clinical Microbiology, 2004
- Hepatitis C Virus Genotype 5: Epidemiological Characteristics and Sensitivity to Combination Therapy with Interferon‐α plus RibavirinThe Journal of Infectious Diseases, 2004
- Efficient Initiation of HCV RNA Replication in Cell CultureScience, 2000
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999
- Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countriesJournal of General Virology, 1995
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989